SAMANTHA ETHRIDGE: Open Payments
NPI 1417355819 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 41 payments from 7 companies in 2025. Trend: 2023 $1,089 · 2024 $899 · 2025 $920
Food & beverage: $920
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $335 |
| Gilead Sciences, Inc. | 12 | $282 |
| GlaxoSmithKline, LLC. | 1 | $124 |
| Dexcom, Inc. | 2 | $96 |
| Lilly USA, LLC | 2 | $33 |
| Cipher Pharmaceuticals US LLC | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: UBRELVY, AREXVY, DEXCOM G7 GSS (161), QULIPTA, MOUNJARO, Natroba, MAVYRET, BREZTRI.
Industry payments across TX — which companies pay providers there.
